HHS Stock Analysis: Buy, Sell, or Hold?
$2.43
0.02 (0.62%)
▲
5d:
+5.19%
30d:
-2.8%
90d:
-2.8%
BUY
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 06, 2026
22d
Get Alerted When HHS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HHS shows positive signals but monitor for confirmation. Market pricing in 4.6% decline. Moderate conviction.
💡 BUY OPPORTUNITY: HHS shows positive signals but monitor for confirmation. Market pricing in 4.6% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.90
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.42
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HHS is currently trading at $2.43, which is considered fair relative to its 30-day fair value range of $2.25 to $2.50. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.3) compared to its historical average (2.6). Remarkably, the market is currently pricing in an annual earnings decline of 4.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HHS is in a downtrend. The price is currently testing key support at $2.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.50 (+624.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HHS is in a downtrend. The price is currently testing key support at $2.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.50 (+624.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.25 -
$2.50
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 624.6% below Wall St target ($17.50)
Trading Range Analysis
30-Day Trading Range
$2.25 -
$2.50
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.50
Resistance Level
$2.69
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.26
Wall Street Target
$17.50
(+624.6%)
Revenue Growth (YoY)
-10.3%
Earnings Growth (YoY)
-90.3%
Profit Margin
-0.7%
Valuation Discount vs History
-4.6% cheaper
PE vs Historical
2.3 vs 2.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.6%
(market-implied from PE analysis)
1-Year Target
$2.30
(-5%)
2-Year Target
$2.20
(-9%)
3-Year Target
$2.10
(-13%)
3-Yr Target (if PE normalizes)
(PE: 2→3)
$2.42
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.3 to 2.6
Stabilization Target:
$2.78
(+15.2%)
PE Expansion Potential:
+15.2%
Share & Embed Analysis
Last updated: July 14, 2026 2:12 PM ET
Data refreshes hourly during market hours. Next update: 3:12 PM
Data refreshes hourly during market hours. Next update: 3:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HHS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Conglomerates Stocks
Top-rated stocks in Conglomerates by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HON
Honeywell International … |
BUY
26 analysts |
$246 | 59 HOLD |
|
MMM
3M Company |
BUY
19 analysts |
$171 | 55 HOLD |
|
BBU
Brookfield Business Part… |
STRONG BUY
6 analysts |
$41 | 58 HOLD |
|
VMI
Valmont Industries Inc |
STRONG BUY
5 analysts |
$611 | 55 HOLD |
|
PAM
Pampa Energia SA ADR |
BUY
8 analysts |
$117 | 63 BUY |